148 related articles for article (PubMed ID: 30472699)
21. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita.
Du H; Guo Y; Ma D; Tang K; Cai D; Luo Y; Xie C
Medicine (Baltimore); 2018 May; 97(19):e0724. PubMed ID: 29742735
[TBL] [Abstract][Full Text] [Related]
22. [Dyskeratosis congenita: an update].
Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility gene card for: dyskeratosis congenita.
Dokal I; Vulliamy T; Mason P; Bessler M
Eur J Hum Genet; 2011 Nov; 19(11):. PubMed ID: 21610750
[No Abstract] [Full Text] [Related]
24. Structure of the Shq1-Cbf5-Nop10-Gar1 complex and implications for H/ACA RNP biogenesis and dyskeratosis congenita.
Li S; Duan J; Li D; Ma S; Ye K
EMBO J; 2011 Nov; 30(24):5010-20. PubMed ID: 22117216
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic non-cirrhotic portal hypertension in dyskeratosis congenita with rare variant of NHP2.
Niu Q; Shang X; Liu Y; Wang X; Gou C; Li X
QJM; 2023 Jul; 116(7):553-555. PubMed ID: 36943377
[No Abstract] [Full Text] [Related]
26. [Genotype analysis and telomere length measure in patients with dyskeratosis congenita].
Zhang JY; An WB; Zhang L; Chang LX; Qi BQ; Liu TF; Liu F; Yang WY; Guo Y; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):212-6. PubMed ID: 25687075
[TBL] [Abstract][Full Text] [Related]
27. Dyskeratosis congenita.
Dokal I
Hematology Am Soc Hematol Educ Program; 2011; 2011():480-6. PubMed ID: 22160078
[TBL] [Abstract][Full Text] [Related]
28. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
Li F; Li W; Qiao X; Xie X
Int J Hematol; 2019 Mar; 109(3):328-335. PubMed ID: 30604317
[TBL] [Abstract][Full Text] [Related]
29. Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita.
Aslan D; Akata RF; Holme H; Vulliamy T; Dokal I
Int Ophthalmol; 2012 Dec; 32(6):615-22. PubMed ID: 22814958
[TBL] [Abstract][Full Text] [Related]
30. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita.
Kanegane H; Kasahara Y; Okamura J; Hongo T; Tanaka R; Nomura K; Kojima S; Miyawaki T
Br J Haematol; 2005 May; 129(3):432-4. PubMed ID: 15842668
[TBL] [Abstract][Full Text] [Related]
31. CTC1 Mutations in a patient with dyskeratosis congenita.
Keller RB; Gagne KE; Usmani GN; Asdourian GK; Williams DA; Hofmann I; Agarwal S
Pediatr Blood Cancer; 2012 Aug; 59(2):311-4. PubMed ID: 22532422
[TBL] [Abstract][Full Text] [Related]
32. Dyskeratosis congenita associated with leukoplakia of the tongue.
Noto Z; Tomihara K; Furukawa K; Noguchi M
Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
[TBL] [Abstract][Full Text] [Related]
33. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
Vulliamy TJ; Dokal I
Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
[TBL] [Abstract][Full Text] [Related]
34. Dyskeratosis congenita caused by a novel TERT point mutation in siblings with pancytopenia and exudative retinopathy.
Sharma A; Myers K; Ye Z; D'Orazio J
Pediatr Blood Cancer; 2014 Dec; 61(12):2302-4. PubMed ID: 25067791
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility gene card for: Dyskeratosis congenita - update 2015.
Dokal I; Vulliamy T; Mason P; Bessler M
Eur J Hum Genet; 2015 Apr; 23(4):. PubMed ID: 25182133
[No Abstract] [Full Text] [Related]
36. Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases.
Dvorak LA; Vassallo R; Kirmani S; Johnson G; Hartman TE; Tazelaar HD; Leslie KO; Colby TV; Cockcroft DW; Churg AM; Yi ES
Hum Pathol; 2015 Jan; 46(1):147-52. PubMed ID: 25455995
[TBL] [Abstract][Full Text] [Related]
37. Inherited SHQ1 mutations impair interaction with NAP57/dyskerin, a major target in dyskeratosis congenita.
Bizarro J; Meier UT
Mol Genet Genomic Med; 2017 Nov; 5(6):805-808. PubMed ID: 29178645
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and genetic characteristics of a patient with dyskeratosis congenita].
Li JG; Li Y; Lin ZM; Ma ZH; Li JH; Liu R; Shi XD; Yang Y; Wang TY
Zhonghua Er Ke Za Zhi; 2009 Nov; 47(11):867-70. PubMed ID: 20079002
[TBL] [Abstract][Full Text] [Related]
39. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Ballew BJ; Savage SA
Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
[TBL] [Abstract][Full Text] [Related]
40. A unique case of coats plus syndrome and dyskeratosis congenita in a patient with CTC1 mutations.
Han E; Patel NA; Yannuzzi NA; Laura DM; Fan KC; Negron CI; Prakhunhungsit S; Thorson WL; Berrocal AM
Ophthalmic Genet; 2020 Aug; 41(4):363-367. PubMed ID: 32543263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
